Pharmarise HoldingsPharmarise Holdings Corporation2796東証スタンダードサービス業FY ending May 2026, consolidated, J-GAAP

What does Pharmarise Holdings do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Operating cash flow
¥3.28B
Capex
¥721M
of revenue 1.0%
Free cash flow
¥2.56B
Returned to shareholders
¥158M
of net income: 139%
Dividend per share
¥14
Payout ratio (reported)
102.0%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥114M
Operating cash flow¥3.28B
Cash conversion (operating CF ÷ operating income)
334.8%
Cash vs. profit gap
¥3.16B(純利益の 2775.4%)
Shareholder payments — dividends
of net income 138.6% · of FCF 6.2%
CapEx intensity (capex ÷ revenue)
1.0%
Investing CF relative to operating CF
60.3%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow¥3.28B
FY ending May 2022: ¥713M¥713MFY ending May 2023: ¥2.52B¥2.52BFY ending May 2024: ¥2.71B¥2.71BFY ending May 2025: ¥1.31B¥1.31BFY ending May 2026: ¥3.28B¥3.28BFY22FY23FY24FY25FY26
Free cash flow¥2.56B
FY ending May 2022: ¥247M¥247MFY ending May 2023: ¥1.98B¥1.98BFY ending May 2024: ¥2.1B¥2.1BFY ending May 2025: ¥609M¥609MFY ending May 2026: ¥2.56B¥2.56BFY22FY23FY24FY25FY26
Net income¥114M
FY ending May 2022: ¥447M¥447MFY ending May 2023: ¥333M¥333MFY ending May 2024: -¥351M-¥351MFY ending May 2025: -¥367M-¥367MFY ending May 2026: ¥114M¥114MFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第40期(2025/06/01-2026/05/31)

    ID S100YXWI2026-08-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第39期(2024/06/01-2025/05/31)

    ID S100WL4W2025-08-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第38期(2023/06/01-2024/05/31)

    ID S100UB272024-08-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第37期(2022/06/01-2023/05/31)

    ID S100RSFU2023-08-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第36期(令和3年6月1日-令和4年5月31日)

    ID S100P3F92022-08-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第35期(令和2年6月1日-令和3年5月31日)

    ID S100MCTA2021-08-27Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.